Cell-targeting peptides which improve tissue-specific delivery of antisense oligonucleotides (AONs) are a new exciting "next-generation" potential AON therapy. New peptides are regularly developed which increase targeting and cell penetration for the AON treatment of mRNA misregulated diseases. Optimization of these peptide conjugate AONs requires systematic treatment and methods of analysis. This chapter describes methods for analyzing cell-targeting peptide conjugated AONs in primary cultur...Expand abstract
- Publisher copy:
- Copyright date:
Optimizing tissue-specific antisense oligonucleotide-peptide conjugates.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record